The Vaccine Adjuvants Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of vaccine adjuvants has experienced significant growth recently. By 2025, it is projected to expand from $1.89 billion in 2024 to $2.03 billion, growing at a Compound Annual Growth Rate (CAGR) of 7.6%.
The Vaccine Adjuvants Global Market is projected to grow to $2.89 billion in 2029, with a compound annual growth rate (CAGR) of 9.2%.
Download Your Free Sample of the 2025 Vaccine Adjuvants Market Report and Uncover Key Trends Now!The key drivers in the vaccine adjuvants market are:
• Global preparedness for pandemics and epidemics
• Broadening scope and portfolio of available vaccines
• Worldwide targets and initiatives for immunization
• Collaborations and partnerships in the industry aimed at vaccine development
The vaccine adjuvants market covered in this report is segmented –
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases
The key trends in the vaccine adjuvants market are:
• There is a growing trend of advancements in adjuvant technologies within the vaccine development industry.
• Focus on enhancement of immunogenicity is seen as a key future trend in the vaccine adjuvants market.
• The use of combination adjuvants for increased effectiveness reflects a notable emerging trend.
• Personalized vaccines and adjuvants constitute a significant future trend shaping the global market.
The major players in the vaccine adjuvants market are:
• GlaxoSmithKline Plc
North America was the largest region in the vaccine adjuvants market in 2024